Sonnet BioTherapeutics Holdings, Inc.

SONN · NASDAQ
Analyze with AI
6/30/2025
3/31/2025
12/31/2024
9/30/2024
Operating Activities
Net Income-$4-$3-$3-$3
Dep. & Amort.$0$0$0$0
Deferred Tax$0$0$0$0
Stock-Based Comp.$0$0$0-$0
Change in WC$2$1$0-$0
Other Non-Cash$0$0$0$0
Operating Cash Flow-$2-$2-$3-$3
Investing Activities
PP&E Inv.$0$0$0$0
Net Acquisitions$0$0$0$0
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.$0-$0$0$0
Investing Cash Flow$0-$0$0$0
Financing Activities
Debt Repay.$0$0$0$0
Stock Issued$0$0$8-$0
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.-$0-$0-$0-$0
Financing Cash Flow$0-$0$8-$0
Forex Effect$0$0$0$0
Net Chg. in Cash-$2-$3$5-$3
Supplemental Information
Beg. Cash$2$5$0$4
End Cash$0$2$5$0
Free Cash Flow-$2-$2-$3-$3
Sonnet BioTherapeutics Holdings, Inc. (SONN) Financial Statements & Key Stats | AlphaPilot